Correlation Between NewAmsterdam Pharma and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Monte Rosa Therapeutics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Monte Rosa.
Diversification Opportunities for NewAmsterdam Pharma and Monte Rosa
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NewAmsterdam and Monte is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Monte Rosa go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Monte Rosa
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Monte Rosa. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 2.71 times less risky than Monte Rosa. The stock trades about -0.01 of its potential returns per unit of risk. The Monte Rosa Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 703.00 in Monte Rosa Therapeutics on August 25, 2024 and sell it today you would earn a total of 146.00 from holding Monte Rosa Therapeutics or generate 20.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Monte Rosa Therapeutics |
NewAmsterdam Pharma and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Monte Rosa
The main advantage of trading using opposite NewAmsterdam Pharma and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Monte Rosa vs. Eliem Therapeutics | Monte Rosa vs. HCW Biologics | Monte Rosa vs. Scpharmaceuticals | Monte Rosa vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |